# Glenn Gandelman, M.D. – FDA Inspection, Mar 10, 2023

Source: https://www.keypedia.com/records/fda_inspections/glenn-gandelman-md/9c928dd2-694b-481b-9730-3794c2b48a30
Source feed: FDA_Inspections

> FDA inspection 1200341 of Glenn Gandelman, M.D., March 10, 2023. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR parts 50 and 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1200341
- Company Name: Glenn Gandelman, M.D.
- Inspection Date: 2023-03-10
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/matthew-c-watson/a1594b84-f65a-42f9-a06d-a68a49eb4b28)

Company: https://www.keypedia.com/companies/glenn-gandelman-md/6517be7a-9082-4dc0-b6b2-bf2e5d785414

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
